Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism

por Kočovská, Eva, Gaughran, Fiona, Krivoy, Amir, Meier, Ute-Christiane
Publicado 2017

S41. SHORT- AND LONG-TERM OUTCOMES OF VITAMIN D SUPPLEMENTATION IN CLOZAPINE TREATED CHRONIC SCHIZOPHRENIA PATIENTS

por Krivoy, Amir, Onn, Roy, Vilner, Yael, Friedman, Zvika, Weizman, Abraham
Publicado 2018

M152. IS MEDICAL SERVICES UTILISATION A MODERATING FACTOR OF EARLY EXCESS MORTALITY IN PATIENTS WITH SCHIZOPHRENIA

por Krivoy, Amir, Hoshen, Moshe, Weiser, Mark, Balicer, Ran, Weizman, Abraham
Publicado 2020

When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity

por Lowe, Penelope, Krivoy, Amir, Porffy, Lilla, Henriksdottir, Erna, Eromona, Whiskey, Shergill, Sukhwinder S.
Publicado 2017

Rapid-onset clozapine-induced loss of glycaemic control: case report

por Porras-Segovia, Alejandro, Krivoy, Amir, Horowitz, Mark, Thomas, George, Bolstridge, Mark, Ion, Dragos, Shergill, Sukhwinder S.
Publicado 2017

Predicting Affect Classification in Mental Status Examination Using Machine Learning Face Action Recognition System: A Pilot Study in Schizophrenia Patients

por Barzilay, Ran, Israel, Nadav, Krivoy, Amir, Sagy, Roi, Kamhi-Nesher, Shiri, Loebstein, Oren, Wolf, Lior, Shoval, Gal
Publicado 2019

Trends of new-onset psychosis or mania in psychiatric emergency departments during the COVID19 pandemic: a longitudinal comparative study

por Segev, Aviv, Hirsch-Klein, Efrat, Kotz, Gershon, Kamhi-Nesher, Shiri, Halimi, Shikma, Qashu, Khalil, Schreiber, Ephraim, Krivoy, Amir
Publicado 2021

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations

por Krivoy, Amir, Whiskey, Eromona, Webb-Wilson, Henrietta, Joyce, Dan, Tracy, Derek K., Gaughran, Fiona, MacCabe, James H., Shergill, Sukhwinder S.
Publicado 2021

Clozapine blood level assessment using a point-of-care device: feasibility and reliability

por Kamhi-Nesher, Shiri, Taub, Sharon, Halimi, Shikma, Frenkel, Maria, Azam, Mahmud, Bormant, Gil, Isakov, Helena, Radzinsky, Dikla, Weizman, Abraham, Krivoy, Amir
Publicado 2022

Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote

por Weitman, Michal, Eisenkraft, Arik, TaShma, Zeev, Makarovsky, Igor, Last, David, Daniels, Dianne, Guez, David, Shneor, Ran, Mardor, Yael, Nudelman, Abraham, Krivoy, Amir
Publicado 2022

Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

por Krivoy, Amir, Onn, Roy, Vilner, Yael, Hochman, Eldar, Weizman, Shira, Paz, Amir, Hess, Shmuel, Sagy, Roi, Kimhi-Nesher, Shiri, Kalter, Ehud, Friedman, Tal, Friedman, Zvi, Bormant, Gil, Trommer, Sharon, Valevski, Avi, Weizman, Abraham
Publicado 2017

Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis: The DFEND Randomized Clinical Trial

por Gaughran, Fiona, Stringer, Dominic, Wojewodka, Gabriella, Landau, Sabine, Smith, Shubulade, Gardner-Sood, Poonam, Taylor, David, Jordan, Harriet, Whiskey, Eromona, Krivoy, Amir, Ciufolini, Simone, Stubbs, Brendon, Casetta, Cecilia, Williams, Julie, Moore, Susan, Allen, Lauren, Rathod, Shanaya, Boardman, Andrew, Khalifa, Rehab, Firdosi, Mudasir, McGuire, Philip, Berk, Michael, McGrath, John
Publicado 2021

Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled...

por Gaughran, Fiona, Stringer, Dominic, Berk, Michael, Smith, Shubulade, Taylor, David, Whiskey, Eromona, Landau, Sabine, Murray, Robin, McGuire, Philip, Gardner-Sood, Poonam, Wojewodka, Gabriella, Ciufolini, Simone, Jordan, Harriet, Clarke, Jessie, Allen, Lauren, Krivoy, Amir, Stubbs, Brendon, Lowe, Philippa, Arbuthnott, Maurice, Rathod, Shanaya, Boardman, Andrew, Firdosi, Mudasir, McGrath, John J.
Publicado 2020